Fairvalue-Calculator Fairvalue-Calculator
EN DE

UnicoCell Biomed Co (6794) Fair Value & Analysis

Healthcare · TW · Market cap 5.1B TWD

Price78.90 TWD
Fair Value40.80 TWD
Upside-48.3%
Quality95/100
Evidence: Low Range 30.60 TWD – 51.00 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

UnicoCell Biomed Co (6794) currently trades at 78.90 TWD, while our model-based Fair Value estimate is 40.80 TWD — implying the stock looks roughly 48.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs in Taiwan and Japan. The company develops ELIXCYTE for the treatment of knee osteoarthritis and chronic kidney disease. It also operates an allogeneic adipose stem cell bank. In addition, the company offers autologous stem cell therapy; conditioned medium; UnicoVial, a cryogenic vial for the storage of cell products and biological samples under ultra-low temperature; and laboratory testing services, which include sterility, endotoxin, mycoplasma, and cell count and viability tests, as well as contract development and manufacturing organization (CDMO) services for cell-based products. UnicoCell Biomed Co., Ltd. was founded in 2011 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is UnicoCell Biomed Co (6794) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 40.80 TWD versus a price of 78.90 TWD — about −48% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6794?
Our 21-model fair value for UnicoCell Biomed Co is 40.80 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 78.90 TWD.
What is the quality score of 6794?
UnicoCell Biomed Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.